Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Bispecific Antibodies: Clinical Trial Tracker - Product Thumbnail Image

Bispecific Antibodies: Clinical Trial Tracker

  • Clinical Trials
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Adenoid Cystic Carcinoma Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Adenoid Cystic Carcinoma Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 81 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2018 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2018

  • Report
  • 55 Pages
From
Glucocorticoid induced tumor necrosis factor -Pipeline Insight, 2018 - Product Thumbnail Image

Glucocorticoid induced tumor necrosis factor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022 - Product Thumbnail Image

Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022

  • Report
  • 80 Pages
From
Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016 - Product Thumbnail Image

Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016

  • Report
  • 57 Pages
From
Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • 36 Pages
From
Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape - Product Thumbnail Image

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

  • Report
  • 138 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Report
  • 2237 Pages
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016

  • Report
  • 250 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Report
  • 450 Pages
From
Metastatic Colorectal Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Review, H2 2016

  • Report
  • 727 Pages
From
Metastatic Breast Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • Report
  • 1096 Pages
From
Loading Indicator
adroll